Publication | Closed Access

Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy

OncologyPhase Ii TrialGastrointestinal OncologyMedicineOxaliplatin-based ChemotherapyColorectal CancerPathologyMetastatic Colorectal CancerCancer TreatmentPharmacologyRadiation Oncology